NOTICE – The Fonds de recherche du Québec (FRQ) was established on June 1, 2024, in accordance with the Act to amend the Act respecting the Ministère de l’Économie et de l’Innovation with respect to research. The Fonds de recherche du Québec – Nature et technologies (FRQNT), the Fonds de recherche du Québec – Santé (FRQS) and the Fonds de recherche du Québec – Société et culture (FRQSC) have since been regrouped into the new FRQ, which continues their existence. The rights and obligations of the FRQNT, FRQS and FRQSC have become those of the FRQ; activities continue as usual.

Please note that if you come across an old name or logo of one of the Fonds de recherche du Québec in the program rules or on the website, it should now read as follows:

  • The FRQNT becomes the Nature et technologies sector;
  • The FRQS becomes the Santé sector;
  • The FRQSC becomes the Société et culture sector.

Thank you for your understanding.

Back to stories & reports

Marc-Antoine Campeau

Postdoctoral fellow in Chemical Engineering
McGill University

Pward-winning publication: Empagliflozin mitigates endothelial inflammation and attenuates endoplasmic reticulum stress signaling caused by sustained glycocalyx disruption (see abstract)

Published in: Scientific Reports